News & Events | Article
Heptares To Present At 5th CNS Partnering And Deal-Making Conference
Welwyn Garden City, UK and Boston, MA, USA, 12 September 2012 – Heptares Therapeutics, the leading GPCR drug discovery company, announces that its President, Dan Grau, will represent the Company at the 5th CNS Partnering and Deal-making conference, which takes place at the Hilton San Francisco Financial District, San Francisco, CA (13-14 September).
On 13 September, Mr Grau will be part of a panel discussion at 2:30pm (PST) entitled “Partnering in the AD, PD and other Cognitive Disorders. How Have Things Changed?”
On 14 September, Mr Grau will give a presentation in the Licensing and Partnering Strategies session at 10:15am (PST) entitled “Back to the Future in Neuroscience: A New Approach to Old (and Validated) Targets.”